Found: 757
Select item for more details and to access through your institution.
White matter integrity between left basal ganglia and left prefrontal cortex is compromised in gambling disorder.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Influence of glucagon-like peptide 1 on fasting glycemia in type 2 diabetic patients treated with insulin after sulfonylurea secondary failure.
- Published in:
- 1998
- By:
- Publication type:
- journal article
GLP-1 tablet in type 2 diabetes in fasting and postprandial conditions.
- Published in:
- 1997
- By:
- Publication type:
- journal article
Glucagon-like peptide I enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Subcutaneous injection of the incretin hormone glucagon-like peptide 1 abolishes postprandial glycemia in NIDDM.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Effect of glucagon-like peptide-1(7-36)-amide on initial splanchnic glucose uptake and insulin action in humans with type 1 diabetes.
- Published in:
- 2001
- By:
- Publication type:
- journal article
Effect of glucagon-like peptide 1(7-36) amide on glucose effectiveness and insulin action in people with type 2 diabetes.
- Published in:
- 2000
- By:
- Publication type:
- journal article
Dipeptidyl peptidase IV inhibition potentiates the insulinotropic effect of glucagon-like peptide 1 in the anesthetized pig.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Evidence for a major role for glucagon in regulation of plasma glucose in conscious, nondiabetic, and alloxan-induced diabetic rabbits.
- Published in:
- 1996
- By:
- Publication type:
- journal article
Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Glucagon immunoneutralization in diabetic rats normalizes urea synthesis and decreases nitrogen wasting.
- Published in:
- 1992
- By:
- Publication type:
- journal article
Determinants of Fasting Hyperglucagonemia in Patients with Type 2 Diabetes and Nondiabetic Control Subjects.
- Published in:
- Metabolic Syndrome & Related Disorders, 2018, v. 16, n. 10, p. 530, doi. 10.1089/met.2018.0066
- By:
- Publication type:
- Article
Dual-hormone treatment with insulin and glucagon in patients with type 1 diabetes.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Pathophysiology and aetiology of impaired fasting glycaemia and impaired glucose tolerance: does it matter for prevention and treatment of type 2 diabetes?
- Published in:
- Diabetologia, 2009, v. 52, n. 9, p. 1714, doi. 10.1007/s00125-009-1443-3
- By:
- Publication type:
- Article
The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men.
- Published in:
- Diabetologia, 2009, v. 52, n. 7, p. 1298, doi. 10.1007/s00125-009-1307-x
- By:
- Publication type:
- Article
Circadian rhythms of GIP and GLP1 in glucose-tolerant and in type 2 diabetic patients after biliopancreatic diversion.
- Published in:
- Diabetologia, 2009, v. 52, n. 5, p. 873, doi. 10.1007/s00125-009-1288-9
- By:
- Publication type:
- Article
Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms.
- Published in:
- 2009
- By:
- Publication type:
- Correction Notice
Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes.
- Published in:
- Diabetologia, 2009, v. 52, n. 2, p. 199, doi. 10.1007/s00125-008-1195-5
- By:
- Publication type:
- Article
Glucokinase, the pancreatic glucose sensor, is not the gut glucose sensor.
- Published in:
- Diabetologia, 2009, v. 52, n. 1, p. 154, doi. 10.1007/s00125-008-1183-9
- By:
- Publication type:
- Article
Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas.
- Published in:
- Diabetologia, 2008, v. 51, n. 12, p. 2263, doi. 10.1007/s00125-008-1149-y
- By:
- Publication type:
- Article
Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action.
- Published in:
- Diabetologia, 2008, v. 51, n. 5, p. 853, doi. 10.1007/s00125-008-0951-x
- By:
- Publication type:
- Article
Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes.
- Published in:
- Diabetologia, 2008, v. 51, n. 4, p. 632, doi. 10.1007/s00125-008-0943-x
- By:
- Publication type:
- Article
Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and/or impaired glucose tolerance in the EUGENE2 study.
- Published in:
- Diabetologia, 2008, v. 51, n. 3, p. 502, doi. 10.1007/s00125-007-0899-2
- By:
- Publication type:
- Article
Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 ( TCF7L2) gene polymorphisms.
- Published in:
- 2008
- By:
- Publication type:
- Correction Notice
Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 ( TCF7L2) gene polymorphisms.
- Published in:
- Diabetologia, 2007, v. 50, n. 12, p. 2443, doi. 10.1007/s00125-007-0753-6
- By:
- Publication type:
- Article
The alpha cell expresses glucagon-like peptide-2 receptors and glucagon-like peptide-2 stimulates glucagon secretion from the rat pancreas.
- Published in:
- Diabetologia, 2007, v. 50, n. 10, p. 2135, doi. 10.1007/s00125-007-0761-6
- By:
- Publication type:
- Article
Inappropriate suppression of glucagon during OGTT but not during isoglycaemic i.v. glucose infusion contributes to the reduced incretin effect in type 2 diabetes mellitus.
- Published in:
- Diabetologia, 2007, v. 50, n. 4, p. 797, doi. 10.1007/s00125-006-0566-z
- By:
- Publication type:
- Article
Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects.
- Published in:
- Diabetologia, 2007, v. 50, n. 4, p. 806, doi. 10.1007/s00125-007-0598-z
- By:
- Publication type:
- Article
Exendin-4, but not glucagon-like peptide-1, is cleared exclusively by glomerular filtration in anaesthetised pigs.
- Published in:
- Diabetologia, 2006, v. 49, n. 4, p. 706, doi. 10.1007/s00125-005-0128-9
- By:
- Publication type:
- Article
Glucagon-like peptide 1 abolishes the postprandial rise in triglyceride concentrations and lowers levels of non-esterified fatty acids in humans.
- Published in:
- Diabetologia, 2006, v. 49, n. 3, p. 452, doi. 10.1007/s00125-005-0126-y
- By:
- Publication type:
- Article
The metabolite generated by dipeptidyl-peptidase 4 metabolism of glucagon-like peptide-1 has no influence on plasma glucose levels in patients with type 2 diabetes.
- Published in:
- Diabetologia, 2006, v. 49, n. 2, p. 369, doi. 10.1007/s00125-005-0098-y
- By:
- Publication type:
- Article
Glucagon-like peptide-1: from extract to agent. The Claude Bernard Lecture, 2005.
- Published in:
- Diabetologia, 2006, v. 49, n. 2, p. 253, doi. 10.1007/s00125-005-0107-1
- By:
- Publication type:
- Article
Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia.
- Published in:
- Diabetologia, 2005, v. 48, n. 11, p. 2236, doi. 10.1007/s00125-005-1933-x
- By:
- Publication type:
- Article
Impact of cereal fibre on glucose-regulating factors.
- Published in:
- Diabetologia, 2005, v. 48, n. 11, p. 2343, doi. 10.1007/s00125-005-1941-x
- By:
- Publication type:
- Article
Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
- Published in:
- Diabetologia, 2005, v. 48, n. 9, p. 1872, doi. 10.1007/s00125-005-1863-7
- By:
- Publication type:
- Article
Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig.
- Published in:
- Diabetologia, 2005, v. 48, n. 9, p. 1882, doi. 10.1007/s00125-005-1847-7
- By:
- Publication type:
- Article
Glucagon-like peptide-1 mediates the therapeutic actions of DPP-IV inhibitors.
- Published in:
- Diabetologia, 2005, v. 48, n. 4, p. 612, doi. 10.1007/s00125-005-1705-7
- By:
- Publication type:
- Article
Incretins, insulin secretion and Type 2 diabetes mellitus Incretins and diabetes.
- Published in:
- Diabetologia, 2004, v. 47, n. 3, p. 357, doi. 10.1007/s00125-004-1342-6
- By:
- Publication type:
- Article
Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia J.J. Meier et al.: GIP and glucagon secretion.
- Published in:
- Diabetologia, 2003, v. 46, n. 6, p. 798, doi. 10.1007/s00125-003-1103-y
- By:
- Publication type:
- Article
Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients T. Vilsbøll et al.: Defective insulin response to GIP in Type II diabetes.
- Published in:
- Diabetologia, 2002, v. 45, n. 8, p. 1111, doi. 10.1007/s00125-002-0878-6
- By:
- Publication type:
- Article
Short-term treatment with GLP-1 increases pulsatile insulin secretion in Type II diabetes with no effect on orderliness.
- Published in:
- Diabetologia, 2000, v. 43, n. 5, p. 583, doi. 10.1007/s001250051347
- By:
- Publication type:
- Article
Counterregulatory hormone and symptom responses to hypoglycaemia in people with type 1 diabetes, insulin-treated type 2 diabetes or without diabetes: the Hypo-RESOLVE hypoglycaemic clamp study.
- Published in:
- Acta Diabetologica, 2024, v. 61, n. 5, p. 623, doi. 10.1007/s00592-024-02239-8
- By:
- Publication type:
- Article
Glicentin inhibits gastric acid secretion in the rat.
- Published in:
- Nature, 1982, v. 297, n. 5862, p. 156, doi. 10.1038/297156a0
- By:
- Publication type:
- Article
Relationship of glicentin to proglucagon and glucagon in the porcine pancreas.
- Published in:
- Nature, 1981, v. 289, n. 5797, p. 514, doi. 10.1038/289514a0
- By:
- Publication type:
- Article
Neural regulation of pancreatic hormone secretion by the C-terminal tetrapeptide of CCK.
- Published in:
- Nature, 1980, v. 284, n. 5751, p. 33, doi. 10.1038/284033a0
- By:
- Publication type:
- Article
Behaviour of Silos Supported on Discrete Brackets.
- Published in:
- International Journal of Structural Stability & Dynamics, 2002, v. 2, n. 1, p. 45, doi. 10.1142/S0219455402000415
- By:
- Publication type:
- Article
Lower confidence and increased error sensitivity in OCD patients while learning under volatility.
- Published in:
- Translational Psychiatry, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41398-024-03042-3
- By:
- Publication type:
- Article
Studies in Rats of Combined Muscle and Liver Perfusion and of Muscle Extract Indicate That Contractions Release a Muscle Hormone Directly Enhancing Hepatic Glycogenolysis.
- Published in:
- Journal of Personalized Medicine, 2022, v. 12, n. 5, p. 837, doi. 10.3390/jpm12050837
- By:
- Publication type:
- Article
Impact of postprandial glycaemia on health and prevention of disease.
- Published in:
- Obesity Reviews, 2012, v. 13, n. 10, p. 923, doi. 10.1111/j.1467-789X.2012.01011.x
- By:
- Publication type:
- Article